Cancer Medicine
-
Publication Venue For
- Pembrolizumab in men with heavily treated metastatic castrate-resistant prostate cancer. 2019
- Racial differences in patterns of treatment among men diagnosed with de novo advanced prostate cancer: A SEER-Medicare investigation.. 8:3325-3335. 2019
- Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women.. 8:2503-2513. 2019
- The prognostic significance of PFS24 in follicular lymphoma following firstline immunotherapy: A combined analysis of 3 CALGB trials.. 8:165-173. 2019
- Financial burden among older, long-term cancer survivors: Results from the LILAC study.. 7:4261-4272. 2018
- The combination of a sphingosine kinase 2 inhibitor (ABC294640) and a Bcl-2 inhibitor (ABT-199) displays synergistic anti-myeloma effects in myeloma cells without a t(11;14) translocation. 2018
- Impact of pediatric cancer on family relationships.. 7:1680-1688. 2018
- Racial/ethnic disparities in de novo metastases sites and survival outcomes for patients with primary breast, colorectal, and prostate cancer.. 7:1183-1193. 2018
- Marijuana use and inpatient outcomes among hospitalized patients: analysis of the nationwide inpatient sample database.. 6:320-329. 2017
- Blood-based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance).. 5:2249-2260. 2016
- Real-world treatment practice in patients with advanced melanoma in the era before ipilimumab: results from the IMAGE study.. 5:1436-1443. 2016
- History of chickenpox in glioma risk: a report from the glioma international case-control study (GICC).. 5:1352-1358. 2016
- Recreational physical activity and ovarian cancer risk in African American women.. 5:1319-1327. 2016
- Whole-exome sequencing of breast cancer, malignant peripheral nerve sheath tumor and neurofibroma from a patient with neurofibromatosis type 1.. 4:1871-1878. 2015
- ABO non-O type as a risk factor for thrombosis in patients with pancreatic cancer.. 4:1651-1658. 2015
- Assessing patients' risk of febrile neutropenia: is there a correlation between physician-assessed risk and model-predicted risk?. 4:1153-1160. 2015
- A retrospective analysis of cross-reacting cetuximab IgE antibody and its association with severe infusion reactions.. 4:36-42. 2015
- Clinical effectiveness of posaconazole versus fluconazole as antifungal prophylaxis in hematology-oncology patients: a retrospective cohort study.. 3:667-673. 2014
- Modulation of circulating protein biomarkers following TRC105 (anti-endoglin antibody) treatment in patients with advanced cancer.. 3:580-591. 2014
- Patterns of chemotherapy-associated toxicity and supportive care in US oncology practice: a nationwide prospective cohort study.. 3:434-444. 2014
- Treatment-related complications of radiation therapy after radical prostatectomy: comparative effectiveness of intensity-modulated versus conformal radiation therapy. 3:397-405. 2014
- A phase I study of ABT-510 plus bevacizumab in advanced solid tumors.. 2:316-324. 2013
- Correlation of angiogenic biomarker signatures with clinical outcomes in metastatic colorectal cancer patients receiving capecitabine, oxaliplatin, and bevacizumab.. 2:234-242. 2013
- Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma.. 2:185-195. 2013
- Treatment-related complications of radiation therapy after radical prostatectomy: comparative effectiveness of intensity-modulated versus conformal radiation therapy. 2014